Disclosure recieved from the Mr. sudhir sethi, promoter of the company under regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Sudhir Sethi, a promoter of Beryl Drugs Ltd, has acquired 4,853 equity shares through open market transactions on 11 March 2026. This represents 0.10% of the company's total share capital. Following this acquisition, his individual holding rose from 4,50,290 shares (8.88%) to 4,55,143 shares (8.98%). The disclosure has been filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, with PAN details of the promoter group (Sanjay Sethi, Sangita Sethi, Sudhir Sethi, Soniya Sethi) provided in Part-B of the filing. The total equity share capital of the company remains unchanged at 50,71,700 shares.
This is a small, incremental increase in promoter stake, signalling continued promoter confidence in the company. However, given the tiny size of the purchase (0.10%), it is unlikely to have any meaningful impact on the stock price or shareholder value.